Lipophilic toxicity from the marine dinoflagellate Karenia brevisulcata: use of the brevetoxin neuroblastoma assay to assess toxin presence and concentration

Abstract

A method for assessing the presence and concentration of a major toxin produced by Karenia brevisulcata has been developed, based on the neuroblastoma assay for brevetoxins. This cytotoxicity assay, coupled with observations of the dose–response relationship and of changes in cellular morphology during the assay gave a characteristic toxin ‘signature’. This signature was consistent whether the toxicity was assessed in extracts of shellfish, seawater samples, uni-algal cultures of K. brevisulcata, or in partially purified toxin samples. Using this method it was possible to confirm the presence of this toxicity during a mixed Karenia bloom, and infer that K. brevisulcata toxin (KBT) was the probable cause of the fish and shellfish mortality observed at that time. The neuroblastoma assay thus provides a solution to the problem of confirming the presence of KBT in suspected K. brevisulcata events, even in the absence of a known toxin structure.